Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma

The introduction of targeted therapies like the tyrosine kinase (TKI) and mammalian target of rapamycin (mTOR) inhibitors has improved patients´ survival in general. Nevertheless the prognosis remains limited. Therapies with a new mode of action are urgently warranted, especially those who would pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Autores principales: Bedke, Jens, Kruck, Stephan, Gakis, Georgios, Stenzl, Arnulf, Goebell, Peter J
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2015
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514323/
https://ncbi.nlm.nih.gov/pubmed/25912622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1016657
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares